+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Animal Sedative Market 2024-2028

  • PDF Icon

    Report

  • 135 Pages
  • August 2024
  • Region: Global
  • TechNavio
  • ID: 5639387
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The animal sedative market is forecasted to grow by USD 169.2 million during 2023-2028, accelerating at a CAGR of 5.25% during the forecast period. The report on the animal sedative market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of animal diseases, growing applications of animals in medical research, and growing investment in R&D activities.

The animal sedative market is segmented as below:

By Type

  • Parenteral
  • Oral

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increasing adoption of pet animals as one of the prime reasons driving the animal sedative market growth during the next few years. Also, rising expenditure on veterinary care and enhancing quality of care in animals during diagnosis and surgical procedures will lead to sizable demand in the market.

The report on the animal sedative market covers the following areas:

  • Animal sedative market sizing
  • Animal sedative market forecast
  • Animal sedative market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading animal sedative market vendors that include Akorn Operating Co. LLC, AmerisourceBergen Corp, Bayer AG, Bimeda Holdings Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc., Jurox Pty Ltd., Konig SA, Laboratorios Richmond, Merck KGaA, Modern Veterinary Therapeutics LLC, Orion Corp., Ouro Fino Saude Animal Group, Randlab Pty Ltd., Troy Laboratories Pty Ltd., Virbac Group, and Zoetis Inc. Also, the animal sedative market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Animal Sedative Market 2018 - 2022
Historic Market Size - Data Table on Global Animal Sedative Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
6.3 Parenteral - Market size and forecast 2023-2028
Chart on Parenteral - Market size and forecast 2023-2028 ($ million)
Data Table on Parenteral - Market size and forecast 2023-2028 ($ million)
Chart on Parenteral - Year-over-year growth 2023-2028 (%)
Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
6.4 Oral - Market size and forecast 2023-2028
Chart on Oral - Market size and forecast 2023-2028 ($ million)
Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Chart on Oral - Year-over-year growth 2023-2028 (%)
Data Table on Oral - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share by geography 2023-2028 (%)
Data Table on Market share by geography 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
8.10 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.11 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity by geography
Market opportunity by geography ($ million)
Data Tables on Market opportunity by geography ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
11.4 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
11.5 Ceva Sante Animale
Ceva Sante Animale - Overview
Ceva Sante Animale - Product / Service
Ceva Sante Animale - Key offerings
11.6 Dechra Pharmaceuticals Plc
Dechra Pharmaceuticals Plc - Overview
Dechra Pharmaceuticals Plc - Business segments
Dechra Pharmaceuticals Plc - Key offerings
Dechra Pharmaceuticals Plc - Segment focus
11.7 Elanco Animal Health Inc.
Elanco Animal Health Inc. - Overview
Elanco Animal Health Inc. - Product / Service
Elanco Animal Health Inc. - Key offerings
11.8 Merck KGaA
Merck KGaA - Overview
Merck KGaA - Business segments
Merck KGaA - Key news
Merck KGaA - Key offerings
Merck KGaA - Segment focus
11.9 Orion Corp.
Orion Corp. - Overview
Orion Corp. - Product / Service
Orion Corp. - Key offerings
11.10 Ouro Fino Saude Animal Group
Ouro Fino Saude Animal Group - Overview
Ouro Fino Saude Animal Group - Product / Service
Ouro Fino Saude Animal Group - Key offerings
11.11 Virbac Group
Virbac Group - Overview
Virbac Group - Business segments
Virbac Group - Key news
Virbac Group - Key offerings
Virbac Group - Segment focus
11.12 Zoetis Inc.
Zoetis Inc. - Overview
Zoetis Inc. - Business segments
Zoetis Inc. - Key news
Zoetis Inc. - Key offerings
Zoetis Inc. - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Company Market Positioning
Exhibits 9: Parent Market
Exhibits 10: Data Table on - Parent Market
Exhibits 11: Market characteristics analysis
Exhibits 12: Value Chain Analysis
Exhibits 13: Offerings of companies included in the market definition
Exhibits 14: Market segments
Exhibits 15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Historic Market Size - Data Table on Global Animal Sedative Market 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Type - Market share 2023-2028 (%)
Exhibits 31: Data Table on Type - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Parenteral - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Parenteral - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by Type ($ million)
Exhibits 43: Data Table on Market opportunity by Type ($ million)
Exhibits 44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 45: Chart on Market share by geography 2023-2028 (%)
Exhibits 46: Data Table on Market share by geography 2023-2028 (%)
Exhibits 47: Chart on Geographic comparison
Exhibits 48: Data Table on Geographic comparison
Exhibits 49: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 52: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 53: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 57: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 65: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 68: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 69: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 85: Market opportunity by geography ($ million)
Exhibits 86: Data Tables on Market opportunity by geography ($ million)
Exhibits 87: Impact of drivers and challenges in 2023 and 2028
Exhibits 88: Overview on criticality of inputs and factors of differentiation
Exhibits 89: Overview on factors of disruption
Exhibits 90: Impact of key risks on business
Exhibits 91: Companies covered
Exhibits 92: Matrix on companies position and classification
Exhibits 93: Bayer AG - Overview
Exhibits 94: Bayer AG - Business segments
Exhibits 95: Bayer AG - Key news
Exhibits 96: Bayer AG - Key offerings
Exhibits 97: Bayer AG - Segment focus
Exhibits 98: Boehringer Ingelheim International GmbH - Overview
Exhibits 99: Boehringer Ingelheim International GmbH - Product / Service
Exhibits 100: Boehringer Ingelheim International GmbH - Key news
Exhibits 101: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 102: Ceva Sante Animale - Overview
Exhibits 103: Ceva Sante Animale - Product / Service
Exhibits 104: Ceva Sante Animale - Key offerings
Exhibits 105: Dechra Pharmaceuticals Plc - Overview
Exhibits 106: Dechra Pharmaceuticals Plc - Business segments
Exhibits 107: Dechra Pharmaceuticals Plc - Key offerings
Exhibits 108: Dechra Pharmaceuticals Plc - Segment focus
Exhibits 109: Elanco Animal Health Inc. - Overview
Exhibits 110: Elanco Animal Health Inc. - Product / Service
Exhibits 111: Elanco Animal Health Inc. - Key offerings
Exhibits 112: Merck KGaA - Overview
Exhibits 113: Merck KGaA - Business segments
Exhibits 114: Merck KGaA - Key news
Exhibits 115: Merck KGaA - Key offerings
Exhibits 116: Merck KGaA - Segment focus
Exhibits 117: Orion Corp. - Overview
Exhibits 118: Orion Corp. - Product / Service
Exhibits 119: Orion Corp. - Key offerings
Exhibits 120: Ouro Fino Saude Animal Group - Overview
Exhibits 121: Ouro Fino Saude Animal Group - Product / Service
Exhibits 122: Ouro Fino Saude Animal Group - Key offerings
Exhibits 123: Virbac Group - Overview
Exhibits 124: Virbac Group - Business segments
Exhibits 125: Virbac Group - Key news
Exhibits 126: Virbac Group - Key offerings
Exhibits 127: Virbac Group - Segment focus
Exhibits 128: Zoetis Inc. - Overview
Exhibits 129: Zoetis Inc. - Business segments
Exhibits 130: Zoetis Inc. - Key news
Exhibits 131: Zoetis Inc. - Key offerings
Exhibits 132: Zoetis Inc. - Segment focus
Exhibits 133: Inclusions checklist
Exhibits 134: Exclusions checklist
Exhibits 135: Currency conversion rates for US$
Exhibits 136: Research methodology
Exhibits 137: Information sources
Exhibits 138: Data validation
Exhibits 139: Validation techniques employed for market sizing
Exhibits 140: Data synthesis
Exhibits 141: 360 degree market analysis
Exhibits 142: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global animal sedative market: Akorn Operating Co. LLC, AmerisourceBergen Corp, Bayer AG, Bimeda Holdings Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Jurox Pty Ltd., Konig SA, Laboratorios Richmond, Merck KGaA, Modern Veterinary Therapeutics LLC, Orion Corp., Ouro Fino Saude Animal Group, Randlab Pty Ltd., Troy Laboratories Pty Ltd., Virbac Group, and Zoetis Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing adoption of pet animals."

According to the report, one of the major drivers for this market is the increasing prevalence of animal diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Akorn Operating Co. LLC
  • AmerisourceBergen Corp
  • Bayer AG
  • Bimeda Holdings Ltd.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Chanelle Pharma Group
  • Dechra Pharmaceuticals Plc
  • Elanco Animal Health Inc.
  • Jurox Pty Ltd.
  • Konig SA
  • Laboratorios Richmond
  • Merck KGaA
  • Modern Veterinary Therapeutics LLC
  • Orion Corp.
  • Ouro Fino Saude Animal Group
  • Randlab Pty Ltd.
  • Troy Laboratories Pty Ltd.
  • Virbac Group
  • Zoetis Inc.